SURx-TV
This article was originally published in The Gray Sheet
Executive Summary
Radio frequency bladder neck suspension system gains FDA market clearance for use during a transvaginal approach, easing surgical access and making the procedure less invasive, SURx says. The procedure was cleared for laparoscopic use in January (1"The Gray Sheet" Feb. 18, 2002, p. 17)...
You may also be interested in...
SURx-LP Minimally Invasive RF System For Incontinence To Ship In March
SURx, Inc. anticipates filing a 510(k) for its Solarant non-surgical, radiofrequency (RF) bladder neck suspension device for stress urinary incontinence (SUI) in 2003
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.